doxycycline

(redirected from Doxycycline hyclate)
Also found in: Dictionary, Medical, Wikipedia.
  • noun

Synonyms for doxycycline

an antibiotic derived from tetracycline that is effective against many infections

References in periodicals archive ?
The materials used for the drug delivery study were BCP granules and doxycycline hyclate.
The purpose of this study was to assess if feeding a pelleted diet medicated with 300 mg doxycycline hyclate per kilogram of feed would safely maintain trough plasma doxycycline concentrations higher than 1 [micro]g/mL.
Adding doxycycline hyclate capsules to the program will help meet the health and wellness needs of even more of our customers and associates.
Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Doxycycline Hyclate Delayed-release (DR) Tablets USP, 150 mg.
Periostat is the registered trademark of CollaGenex's proprietary 20 mg tablets of doxycycline hyclate approved by the FDA as the only systemic adjunct to scaling and root planing for the treatment of adult periodontitis.
Investors are cautioned that forward-looking statements involve risks and uncertainties which may affect the company's business and prospects, including the risks that launch of doxycycline hyclate 20 mg tablets may be delayed or may not occur, and if launched, the products will not be successfully commercialized; changing market conditions; the availability and cost of raw materials and other third party products; the impact of competitive products and pricing; the difficulty in predicting the timing and outcome of legal proceedings, including the outcome of CollaGenex Pharmaceuticals, Inc.
The Ocudox(TM) Convenience Kit with its Doxycycline Hyclate 50 mg strength targets acute conditions and offers 60 capsules for variable dosing as determined by the practitioner.
In that case CollaGenex alleges that the Defendants' submissions of ANDA's covering their 20mg tablets of doxycycline hyclate infringe the '656 Patent.
In October 2004 CollaGenex filed a complaint in the United States District Court for the Eastern District of New York alleging that the Defendants' submissions of Abbreviated New Drug Applications ("ANDA's") covering their 20mg tablets of doxycycline hyclate infringe United States Patent RE 34,656, of which CollaGenex is the exclusive licensee.
Therefore, the use of low-dose doxycycline hyclate has demonstrated effective enzyme modulation treatment of inflammatory disease.
Periostat is the registered trademark of CollaGenex's proprietary 20mg tablets of doxycycline hyclate approved as the only systemic adjunct to scaling and root planing for the treatment of adult periodontitis.
3mg Tablets (AB-rated to Catapres), Doxycycline Hyclate 20mg Tablets (AB-rated to Collagenex's Periostat tablets), and Folic Acid 1mg (AA-rated to Watson's Folic Acid).
In that case, CollaGenex alleges that the Defendants' submissions of ANDA's covering their 20mg tablets of doxycycline hyclate infringe United States Patent RE 34,656, of which CollaGenex is the exclusive licensee.
Contributing to URL/Mutual's successes has been the April 2004 launch of Doxycycline Hyclate 20mg Tablet, a lower-cost alternative to Periostat Tablets.
CollaGenex markets its proprietary 20mg tablets of doxycycline hyclate under the registered trademark Periostat(R) for the treatment of adult periodontitis.